ARWR

Arrowhead Pharmaceuticals Inc.

Price

$66.69

return (12m)

p/e

-34.91

p/bv

17.54

DIVIDEND YIELD

0.00%

ARWR price

Arrowhead Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ARWR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals ARWR

Valuation

P/E

-34.91

Sector -4.15

Industry -4.15

P/BV

17.54

Sector 2.06

Industry 2.06

P/Revenue (PSR)

16.89

Sector -4.16

Industry -4.16

EV/EBITDA

-89.07

Sector -241.86

Industry -241.86

EV/EBIT

-84.08

Sector -671.75

Industry -671.75

P/EBITDA

-78.12

Sector -4.30

Industry -4.30

P/EBIT

-65.72

Sector -4.35

Industry -4.35

P/Total Assets

4.63

Sector 1.46

Industry 1.46

P/Net Current Assets

61.64

Sector -12.67

Industry -12.67

P/Working Capital

6.80

Sector -12.58

Industry -12.58

EPS

-2.12

Sector -2.19

Industry -2.19

BVPS

4.22

Sector 1.92

Industry 1.92

Efficiency

Gross Margin

100.00%

Sector 36.44%

Industry 36.44%

EBITDA Margin

-145.58%

Sector -16,748.51%

Industry -16,748.51%

EBIT Margin

-154.22%

Sector -4,256,846.44%

Industry -4,256,846.44%

Operating Margin

-35.67%

Sector -38.78%

Industry -38.78%

Net Profit Margins

-48.38%

Sector -39.93%

Industry -39.93%

Asset Turnover

0.03

Sector 0.03

Industry 0.03

Profitability

ROE

-50.24%

Sector -67.01%

Industry -67.01%

ROA

-13.27%

Sector -66.28%

Industry -66.28%

ROIC

-94.49%

Sector -2,917.75%

Industry -2,917.75%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

6.23

Sector 2.90

Industry 2.90

Net Debt / EBITDA

8.78

Sector -12,252,405.04

Industry -12,252,405.04

Net Debt / EBIT

8.29

Sector -3.79

Industry -3.79

Net Debt / Equity

-1.57

Sector -33,290.93

Industry -33,290.93

Gross Debt / Equity

1.41

Sector 0.00

Industry 0.00

Equity/Assets

0.26

Sector 0.42

Industry 0.42

Liabilities/Assets

0.74

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

33.92%

Sector -

Industry -

5Y Earnings CAGR

10.46%

Sector -

Industry -

Fundamentals ARWR

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ARWR Arrowhead Pharmaceuticals Inc.	$66.69	465.65%	0.00%	-34.91	17.54	-50.24%	-48.38%
AZN AstraZeneca PLC	$204.64	53.45%	1.89%	25.20	5.52	21.93%	17.19%
JNJ Johnson & Johnson	$240.16	62.69%	2.08%	28.83	0.00	-%	21.48%
NBIX Neurocrine Biosciences Inc.	$130.81	43.95%	0.00%	25.46	5.00	19.62%	21.55%
ABEO Abeona Therapeutics Inc.	$5.19	12.83%	0.00%	6.09	2.78	45.63%	100.00%
PFE Pfizer Inc.	$27.11	32.71%	6.97%	18.76	1.55	8.29%	11.83%
ABBV AbbVie Inc.	$210.26	25.08%	2.61%	125.53	-69.01	-54.98%	5.79%
ABUS Arbutus Biopharma Corporation	$4.35	38.54%	0.00%	5.66	3.50	61.77%	83.94%
ACAD ACADIA Pharmaceuticals Inc.	$22.02	51.03%	0.00%	11.55	3.48	30.10%	34.30%
ADMA ADMA Biologics Inc.	$10.49	-45.93%	0.00%	12.58	5.33	42.37%	32.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ARWR Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

States of America

37 years

Founded: 1989

1997

Time since IPO - 29 years

232

Employees

Arrowhead Pharmaceuticals Inc. (States of America) is listed on the Nasdaq and has a market capitalization of $10.50 billion, with shareholders equity totaling $598.92 million.

The company employs approximately 232 people and operates in the Healthcare sector, within the Biotecnologia industry.

Over the past 12 months, Arrowhead Pharmaceuticals Inc. reported $622.01 million in revenue, generating net income of $-300.91 million.

Key financial metrics include a P/E ratio of -34.91, a price-to-book (P/B) ratio of 17.54, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ARWR.

Market cap

$10.50 billion

Net worth

$598.92 million

$598,920,000.00

Assets

$2.27 billion

$2,268,260,000.00

Total Shares Outstanding

142.00 million

142,000,000

Average Daily Trading Volume

$2.21 million

$2,214,704.00

Sector

Healthcare

Industry

Biotecnologia

ARWR

ARWR revenue and profits

Financial Results ARWR

DRAG THE FRAME TO SEE MORE DATA

ARWR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$862.96 22,54% (12M)

P/E

21.66

0.39%

ROE

-570.98%

P/BV

-123.68

CAH - Cardinal Health

$214.95 38,63% (12M)

P/E

34.90

0.89%

ROE

-58.20%

P/BV

-20.31

JNJ - Johnson & Johnson

$240.16 47,25% (12M)

P/E

28.83

2.08%

ROE

P/BV

0.00

MRK - Merck & Co.

$119.96 46,43% (12M)

P/E

35.53

2.62%

ROE

19.45%

P/BV

6.91

AZN - AstraZeneca

$204.64 40,78% (12M)

P/E

25.20

1.89%

ROE

21.93%

P/BV

5.52

ABBV - AbbVie

$210.26 15,08% (12M)

P/E

125.53

2.61%

ROE

-54.98%

P/BV

-69.01

NVO - Novo Nordisk

$39.32 --40,26% (12M)

P/E

11.83

3.68%

ROE

60.40%

P/BV

7.14